Latest Exploration Partnerships News

Charger Metals NL reported steady progress in its June 2025 quarterly activities, advancing lithium exploration at the Lake Johnston Project in Western Australia with funding support from Rio Tinto Exploration. The company awaits further drilling permits to continue testing promising targets.

Race Oncology has successfully dosed the first patient with its RC220 and doxorubicin combination in a Phase 1 trial for advanced solid tumours, reporting no dose-limiting side effects. This milestone marks a key step in evaluating the safety and potential cardioprotective benefits of the novel therapy.

Megado Minerals has completed the acquisition of an 80% stake in the Iberian Copper Project, unlocking nearly 1,000 square kilometres of historic copper and silver mining territory in Spain. The company is accelerating exploration with geological mapping and airborne geophysics ahead of planned drilling later this year.

Thunderbird Resources has entered a strategic option agreement with Mustang Energy, enabling Mustang to acquire up to 80% of two promising uranium projects in Canada’s Athabasca Basin while Thunderbird sharpens its focus on gold-antimony assets in New South Wales.

Helia Group’s 1Q25 APRA lodgement reveals robust growth in gross written premiums and statutory net profit, while the company voices concerns over proposed government changes to the Home Guarantee Scheme that could reshape its market dynamics.

IPB Petroleum Limited has secured a crucial two-year extension on its WA-424-P permit in the Browse Basin, enabling continued exploration and development of its Gwydion asset while maintaining a solid cash position of AUD 1.487 million.

Winsome Resources navigates lithium market headwinds by optimizing capital, progressing the Adina Lithium Project’s regulatory and feasibility milestones, and expanding its strategic footprint with a high-grade cesium-lithium discovery and extended Renard acquisition option.

Race Oncology has opened a second Australian clinical site for its Phase 1 trial of RC220 combined with doxorubicin in advanced solid tumours, aiming to speed patient enrolment and gather critical safety and efficacy data.

New Zealand Coastal Seafoods reports a sharp reduction in losses following the closure of its New Zealand operations and reveals promising initial fishing results in the Coral Sea. The company is actively exploring commercial opportunities for its Coral Sea Fishery permits and a potential acquisition to boost future revenues.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

Investor Centre Limited’s December quarter report reveals a strategic pivot with the withdrawal of its capital raising prospectus, the appointment of a new director, and ongoing talks to expand its wholesale financial services.

Micro-X announces a strategic pivot towards medical imaging, anchored by a $25 million US government contract to develop a portable Full Body CT scanner, while discontinuing its Argus security operations to streamline costs.